The Enterprise Value as of June 2026 (TTM) for PDS Biotechnology Corporation (PDSB) is 52.81M

According to PDS Biotechnology Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 52.81M. This represents a change of 50.32% compared to the average of 35.13M of the last 4 quarters.

PDS Biotechnology Corporation (PDSB) Historical Enterprise Value (quarterly & annually)

How has PDSB Enterprise Value performed in the past?

The mean historical Enterprise Value of PDS Biotechnology Corporation over the last ten years is 111.77M. The current 52.81M Enterprise Value has changed 4.62% with respect to the historical average. Over the past ten years (40 quarters), PDSB's Enterprise Value was at its highest in in the September 2021 quarter at 354.33M. The Enterprise Value was at its lowest in in the December 2018 quarter at -24523309.00.

PDS Biotechnology Corporation (PDSB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of PDS Biotechnology Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

PDS Biotechnology Corporation (PDSB) Average Enterprise Value

How has PDSB Enterprise Value performed in the past?

The current Enterprise Value of PDS Biotechnology Corporation (PDSB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

PDS Biotechnology Corporation (PDSB) Enterprise Value vs. Peers

How is PDSB’s Enterprise Value compared to its peers?

PDS Biotechnology Corporation’s Enterprise Value is greater than Actinium Pharmaceuticals, Inc. (-8924256.00), greater than Xilio Therapeutics, Inc. (-89055595.00), greater than LAVA Therapeutics N.V. (-3892787.00), greater than OnKure Therapeutics, Inc. (-134267880.00), greater than Tempest Therapeutics, Inc. (11.64M), greater than Kezar Life Sciences, Inc. (-11018667.00), greater than FibroGen, Inc. (11.12M), greater than Reviva Pharmaceuticals Holdings, Inc. (-19627463.00), greater than Annovis Bio, Inc. (20.80M), greater than INmune Bio, Inc. (13.12M),

Build a custom stock screener for PDS Biotechnology Corporation (PDSB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PDS Biotechnology Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PDS Biotechnology Corporation (PDSB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PDS Biotechnology Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.